EU ministers call for better access to "valuable" new drugs
This article was originally published in SRA
Executive Summary
EU ministers have called on the European Commission and member states to take steps to give patients equitable access to new, innovative medicines while ensuring that these medicines are of real added value and do not unduly burden countries' health budgets1.